Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07360418 · ClinicalTrials.gov registry record
Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.
A clinical trial of Diabetic Foot Ulcer and Ulcer, sponsored by Applied Biologics.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT07360418: Recruiting study of Diabetic Foot Ulcer and Ulcer, sponsored by Applied Biologics.
NCT07360418 is a study of Diabetic Foot Ulcer and Ulcer that is actively recruiting participants, run by Applied Biologics. The registered enrollment target is 50 participants, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07360418, a study of Diabetic Foot Ulcer and Ulcer, is actively recruiting participants, sponsored by Applied Biologics.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective long-term follow-up on durability of closure evaluated by photographic and thermal scanning.
Primary Outcome
To demonstrate durability of closure (rate of recurrence) of subjects with a closed diabetic foot ulcer during the CAMPX clinical trial comparing subjects treated with Single Layer Amniotic Membrane (SLAM) plus standard of care (SOC) to subjects treated with SOC alone.
Conditions Studied
Interventions
- OTHER Blue Drop Foot Scanner
Study Locations (1)
Michigan
- Detroit Foot and Ankle - Clinton Township
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-10-16 |
| Est. Completion | 2027-10 |
What NCT07360418 shows while recruiting
NCT07360418 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (80% lower).
The record links to 4 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Blue Drop Foot Scanner is the first listed.
NCT07360418 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07360418 about?
NCT07360418 is a clinical study titled "Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.". Prospective long-term follow-up on durability of closure evaluated by photographic and thermal scanning.
What is the current status of trial NCT07360418?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-10-16. Estimated completion is 2027-10.
What conditions does trial NCT07360418 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Ulcer, Foot Ulcer Chronic, Diabetic Foot Ulcers (DFU).
What interventions are being tested in trial NCT07360418?
The interventions under investigation include: Blue Drop Foot Scanner (OTHER).
Who is sponsoring clinical trial NCT07360418?
This trial is sponsored by Applied Biologics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07360418 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07360418's enrollment target sits among peer trials
50 49th of 67 higher than 18 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
RECRUITING · Phase 2
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI